Cann Group ponders M&A deals, reports ‘strongest cash performance to date’ by Steve Jones July 30, 2026August 5, 2026 Cann Group generated customer receipts of $2.5 million and reported a positive cash flow of $237,000 […]
More funding needed by Cann Group ‘to continue its operations’ by Steve Jones April 29, 2026April 29, 2026
‘Subdued prescriber activity’ blamed by Cann Group for revenue fall by Steve Jones March 2, 2026March 5, 2026
Biortica executive quits cannabis to return to pharma sector by Steve Jones February 4, 2026February 5, 2026
Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue by Steve Jones January 30, 2026February 3, 2026
Three cannabis firms fined by ODC for alleged licence breaches by Steve Jones December 19, 2025December 22, 2025
Cann Group set for ‘stronger future’ after ‘challenging period’, outgoing chair tells shareholders by Steve Jones December 4, 2025February 21, 2026
News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025February 21, 2026
